Deutsche Bank downgraded Aegerion Pharmaceuticals (NASDAQ: AEGR) from Buy to Hold with a price target of $26.00 (from $58.00).Analyst Robyn ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE